LAT Research
Buenos Aires, Argentina· Est.
LATAM CRO delivering rapid, compliant early‑phase trials for rare disease and translational research.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
LATAM CRO delivering rapid, compliant early‑phase trials for rare disease and translational research.
Rare Diseases
Technology Platform
CRO services with fast‑track regulatory approvals, translational medicine unit, biomarker‑driven and adaptive trial design for early‑phase and rare disease studies.
Opportunities
Increasing demand for regional CRO expertise in LATAM, especially for rare disease and early‑phase trials, offers growth potential.
Risk Factors
Regulatory variability across countries and competition from larger global CROs could limit market penetration.
Competitive Landscape
Competes with global CROs like IQVIA and regional firms; differentiation hinges on rapid start‑up, rare disease focus, and translational medicine capabilities.